Whisper Number: How Will PDL BioPharma Investors React to Earnings?

PDL BioPharma (NASDAQ:PDLI) is expected to report earnings on Wednesday, November 6. The whisper number is $0.37, in line with the analysts’ estimate. PDL BioPharma has a 61 percent positive surprise history, having topped the whisper in 11 of the 18 earnings reports for which we have data.

Earnings history:

– Beat whisper: 11 qtrs
– Met whisper: 0 qtrs
– Missed whisper: 3 qtrs

Our primary focus is on post earnings price movement. Knowing how likely a stock’s price will move following an earnings report can help you determine the best action to take (long or short). In other words, we look at what happens when the company beats or misses the whisper number expectation.

The table below indicates the average post earnings price movement within a one and thirty trading day timeframe.

PDLI1113A

The strongest price movement of +8.0 percent comes within thirty trading days when the company reports earnings that beat the whisper number, and +7.3 percent within ten trading days when the company reports earnings that miss the whisper number. The overall average price move is ‘positive’ (beat the whisper number and see strength, miss and see strength) when the company reports earnings.

The table below indicates the most recent earnings reports and short-term price reaction.

PDLI1113B

The company has reported earnings ahead of the whisper number in one of the past four quarters with a whisper number. In the comparable quarter last year, the company did not have a whisper number. Last quarter, the company reported earnings four cents ahead of the whisper number. Following that report, the stock realized a 6.0 percent loss in thirty trading days. Overall historical data indicates the company to be (on average) a ‘positive’ price reactor when the company reports earnings

Enter your expectation and view more earnings information here or let us know your expectation in the comments section below.

John Scherr is the founder and President of WhisperNumber.com, an independent financial research firm focused on earnings expectations. He is a regular contributor to CNBC and Fox Business Network, and has been featured in Barron’s, The Wall Street Journal, and MarketWatch. He is considered a leading expert on ‘whisper numbers’ and post earnings price movement analysis. WhisperNumber.com provides specific earnings trade alerts to take advantage of earnings report price movement with their Whisper Reactors subscription service.

Investing Insights: Will GlaxoSmithKline Continue to Trend Higher?

More from The Cheat Sheet